Logo

American Heart Association

  20
  0


Final ID:

Panel Discussion

  • Wiviott, Stephen  ( Brigham and Womens Hospital , Boston , Massachusetts , United States )
  • Author Disclosures:
    Stephen Wiviott: DO have relevant financial relationships ; Researcher:AstraZeneca:Active (exists now) ; Consultant:ICON:Active (exists now) ; Consultant:NovoNordisk:Active (exists now) ; Researcher:Merck:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

More abstracts on this topic:
TRISCEND II 1-Year Outcomes (primary results at TCT)

Hahn Rebecca, Thourani Vinod, Kodali Susheel

SMART (primary results at ACC)

Mehran Roxana, Herrmann Howard

More abstracts from these authors:
Galectin-3 and Progression of Kidney Disease in Patients With Type 2 Diabetes Mellitus: Analyses From the DECLARE-TIMI 58 Trial

Haller Paul, Mcguire Darren, Raz Itamar, Wilding John, Sabatine Marc, Morrow David, Wiviott Stephen, Berg David, Jarolim Petr, Goodrich Erica, Bhatt Deepak, Cahn Avivit, Gause-nilsson Ingrid, Leiter Lawrence

Polygenic Risk in Heart Failure – Evaluating the Ability of a Polygenic Risk Score to Identify Risk of Future Heart Failure Events in 60,000 Patients from 6 TIMI Randomized Trials

Haller Paul, Giugliano Robert, O'donoghue Michelle, Scirica Benjamin, Wiviott Stephen, Braunwald Eugene, Morrow David, Ellinor Patrick, Sabatine Marc, Ruff Christian, Marston Nicholas, Melloni Giorgio, Berg David, Kamanu Frederick, Lai Yi-pin, Antman Elliott, Bhatt Deepak, Bonaca Marc, Cannon Christopher

You have to be authorized to contact abstract author. Please, Login
Not Available